---
title: "DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference Fireside Chat"
description: "DiaMedica Therapeutics Inc. will participate in a fireside chat at the Cantor Global Healthcare Conference in New York City on September 4, 2025, from 9:10 to 9:40 am ET. President and CEO Rick Pauls "
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/255620840.md"
published_at: "2025-09-02T12:23:12.000Z"
---

# DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference Fireside Chat

> DiaMedica Therapeutics Inc. will participate in a fireside chat at the Cantor Global Healthcare Conference in New York City on September 4, 2025, from 9:10 to 9:40 am ET. President and CEO Rick Pauls and Chief Business Officer Dave Wambeke will present at the event.

DiaMedica Therapeutics Inc., a clinical-stage biopharmaceutical company, will participate in a fireside chat at the Cantor Global Healthcare Conference in New York City. The event will take place on Thursday, September 4, 2025, from 9:10 to 9:40 am ET, where President and CEO Rick Pauls, along with Chief Business Officer Dave Wambeke, will present. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DiaMedica Therapeutics Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250902308181) on September 02, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)

### Related Stocks

- [DMAC.US - DiaMedica Therapeutics](https://longbridge.com/en/quote/DMAC.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Diamyd Medical erhält US-Patentanmeldung für Diabetes-Immuntherapie genehmigt | Diamyd Medical AB has received a Notice of Allowance for a key patent related to its antigen-specific immunotherapy appr | [Link](https://longbridge.com/en/news/275280976.md) |
| DiaMedica Therapeutics Strengthens Balance Sheet With $12.2 Million Capital Raise While Advancing Preeclampsia Program | DiaMedica Therapeutics Inc. has raised $12.2 million through an at-the-market offering to support its clinical programs, | [Link](https://longbridge.com/en/news/275137179.md) |
| Jorie AI Shares a Live Case Study on the Inevitable Future of Healthcare AI at ViVE 2026 | Jorie AI showcased its autonomous healthcare AI solutions at ViVE 2026, emphasizing the need for AI to operate effective | [Link](https://longbridge.com/en/news/275497445.md) |
| ZAWYA-PRESSR: Healthcare leaders call for greater strategic alignment between capital investment and health system strategy at WHX | Global healthcare leaders gathered at the World Health Expo (WHX) to discuss the need for strategic alignment between ca | [Link](https://longbridge.com/en/news/275449733.md) |
| Waldorf Astoria's Chinese owners plan to sell iconic NYC hotel, WSJ reports | The Chinese owners of the Waldorf Astoria in NYC are planning to sell the luxury hotel after its recent reopening follow | [Link](https://longbridge.com/en/news/275682113.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
